scholarly journals Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

2006 ◽  
Vol 2 (2) ◽  
pp. 60-67 ◽  
Author(s):  
Farshad Guirakhoo ◽  
Scott Kitchener ◽  
Dennis Morrison ◽  
Remi Forrat ◽  
Karen McCarthy ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Yellow Fever ◽  
Neutralizing Antibody ◽  
Antibody Responses ◽  
Phase I Clinical Trial

scholarly journals Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial

PLoS Medicine ◽  
2015 ◽  
Vol 12 (3) ◽  
pp. e1001807 ◽  
Author(s):  
Lisa C. Lindesmith ◽  
Martin T. Ferris ◽  
Clancy W. Mullan ◽  
Jennifer Ferreira ◽  
Kari Debbink ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Antibody Responses ◽  
Phase I Clinical Trial ◽  
Candidate Vaccine ◽  
Human Volunteers

scholarly journals A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

2011 ◽  
Vol 203 (10) ◽  
pp. 1396-1404 ◽  
Author(s):  
Julie E. Ledgerwood ◽  
Theodore C. Pierson ◽  
Sarah A. Hubka ◽  
Niraj Desai ◽  
Steve Rucker ◽  
...  
Keyword(s):  
Clinical Trial ◽  
West Nile Virus ◽  
Phase I ◽  
Dna Vaccine ◽  
Neutralizing Antibody ◽  
Healthy Adults ◽  
Phase I Clinical Trial ◽  
West Nile

Phase I clinical trial of donor T-helper Type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

Cytotherapy ◽  
2002 ◽  
Vol 4 (5) ◽  
pp. 429-430 ◽  
Author(s):  
D. Fowler ◽  
J. Hou ◽  
J. Foley ◽  
F. Hakim ◽  
J. Odom ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
T Helper ◽  
Helper Type ◽  
Reduced Intensity

scholarly journals A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

Vaccine ◽  
2008 ◽  
Vol 26 (50) ◽  
pp. 6338-6343 ◽  
Author(s):  
Julie E. Martin ◽  
Mark K. Louder ◽  
LaSonji A. Holman ◽  
Ingelise J. Gordon ◽  
Mary E. Enama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Immune Responses ◽  
Phase I ◽  
Dna Vaccine ◽  
Neutralizing Antibody ◽  
Healthy Adults ◽  
Phase I Clinical Trial ◽  
Cellular Immune Responses ◽  
Cellular Immune
Sign in / Sign up

Export Citation Format

Share Document